Impaired angiotensin II-extracellular signal-regulated kinase signaling in failing human ventricular myocytes

Journal of Hypertension

Volumn 26, Issue 10, 2008, Pages 2030-2039

  Modesti, Pietro Amedeo ^a   Serneri, Gian Gastone Neri ^a   Gamberi, Tania ^a   Boddi, Maria ^a   Coppo, Mirella ^a   Lucchese, Gianluca ^b   Chiavarelli, Mario ^b   Bottai, Giulia ^a   Marino, Francesco ^a   Toz Gensini, Camilla ^a   Franco Gensini, Gian ^a   Modesti, Alessandra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

angiotensin II; c Jun NH2 terminal kinase; cardiomyocytes; endothelin 1; extracellular signal regulated kinase; insulin like growth factor 1; signaling pathways

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CASE CONTROL STUDY; CELL CULTURE; CONGESTIVE CARDIOMYOPATHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANGIOTENSIN II; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIN-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MYOCYTES, CARDIAC;

EID: 58149127422     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328308de68     Document Type: Article

References (48)

1. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75:977-984.
2. Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Polidori G, Paniccia R, et al. Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy. Am J Physiol Heart Circ Physiol 2000; 279:H976-H985.
3. Modesti PA, Zecchi-Orlandini S, Vanni S, PolidoriG, Bertolozzi I, Perna AM, et al. Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor. J Mol Cell Cardiol 2002; 34:1491-1500.
4. Neri Serneri GG, Modesti PA, Boddi M, Cecioni I, Paniccia R, Coppo M, et al. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res 1999; 85:57-67.
5. Neri Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, et al. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 2001; 88:961-968.
6. Cook SA, Sugden PH, Clerk A. Activation of c-Jun N-terminal kinases and p38 mitogen-activated protein kinases in human heart failure secondary to ischemic heart disease. J Mol Cell Cardiol 1999; 31:1429-1434.
7. Communal C, Colucci WS, Remondino A, Sawyer DB, Port JD, Wichman SE, et al. Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. J Card Fail 2002; 8:86-92.
8. Modesti A, Bertolozzi I, Gamberi T, Marchetta M, Lumachi C, Coppo M, et al. Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress. Diabetes 2005; 54:394-401.
9. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 2004; 109:1938-1941.
10. Huang Y, Wright CD, Merkwan CL, Baye NL, Liang Q, Simpson PC, et al. An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 2007; 115:763-772.
11. Pao CI, Lin KW, Zhu J, Wu G, Farmer PK, Phillips LS. In vitro transcription of the rat insulin-like growth factor-I gene. J Biol Chem 1996; 271:8667-8674.
12. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, et al. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004; 61:159-168.
13. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005; 97:663-673.
14. Zhao XS, Pan W, Bekeredjian R, Shohet RV. Endogenous endothelin-1 is required for cardiomyocyte survival in vivo. Circulation 2006; 114:830-837.
15. Cingolani HE, Villa-Abrille MC, Cornelli M, Nolly A, Ennis IL, arciarena C, et al. The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension 2006; 47:727-734.
16. Fullmer SJ, Davies EL, Gillespie-Brown J, Sun H, Tomks NK. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. Biochem J 1997; 323:313-319.
17. Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J, et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl Acad Sci 2007; 104:14074-14079.
18. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993; 92:398-403.
19. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial ?brosis, and cardiac ?broblasts are the major cell type for its expression. Circ Res 1998; 83:1035-1046.
20. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15:2760-2770.
21. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, et al. Glycogen synthase kinase-3b is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000; 151:117-130.
22. Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, RufT, et al. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 1993; 88:1228-1237.
23. Wikman-Coffelt J, Wu ST, Parmley WW, Mason DT. Angiotensin II and phorbol esters depress cardiac performance and decrease diastolic and systolic [Ca2+]i in isolated perfused rat hearts. Am Heart J 1991; 122:786-794.
24. Lefroy DC, Crake T, Del Monte F, Vescovo G, Dalla Libera L, Harding S, Poole-Wilson PA. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol 1996; 270:H2060-H2069.
25. Möllmann H, Schmidt-Schweda S, Nef H, Möllmann S, Burstin JV, Klose S, et al. Contractile effects of angiotensin and endothelin in failing and nonfailing human hearts. Int J Cardiol 2007; 114:34-40.
26. Touyz RM, Fareh J, Thibault G, Tolloczko B, Larivie re R, Schiffrin EL.Modulation of Ca2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1. Am J Physiol 1996; 270:H857-H868.
27. Pe rez NG, Villa-Abrille MC, Aiello EA, Dulce RA, Cingolani HE, amilio nde Hurtado MC. A low dose of angiotensin II increases inotropism through activation of reverse Na(+)/Ca(2+) exchange by endothelin release. Cardiovasc Res 2003; 60:589-597.
28. Alvarez BV, Pe rez NG, Ennis IL, Camilio n de Hurtado MC, Cingolani HE.Mechanisms underlying the increase in force and Ca(2+) transient that follow stretch of cardiac muscle: a possible explanation of the Anrep effect. Circ Res 1999; 85:716-722.
29. Krämer BK, Smith TW, Kelly RA. Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C-dependent Na(+)-H+ exchanger. Circ Res 1991; 68:269-279.
30. Cingolani HE, Ennis IL. Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation 2007; 115:1090-1100.
31. Kudoh S, Komuro I, Mizuno T, Yamazaki T, Zou Y, Shiojima I, et al. Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res 1997; 80:139-146.
32. Sugden PH. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 2003; 35:871-886.
33. Yamakaw K, Kitamura K, Nonoguchi H, Takasu N, Miller RT, Tomita K.Ga13 induces preproET-1 gene expression via JNK. Hypertension Res 2002; 25:427-432.
34. Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR, et al. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 1992; 12:3507-3513.
35. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. denti?cation of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996; 271:14169-14175.
36. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kübler W, Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 2000; 20:940-948.
37. Sadoshima J, Qiu Z, Morgan JP, Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes: the critical role of Ca2+-dependent signaling. Circ Res 1995; 76:1-15.
38. Beuckelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992; 85:1046-1055.
39. Bailey BA, Houser SR. Calcium transients in feline left ventricular myocytes with hypertrophy induced by slow progressive pressure overload. J Mol Cell Cardiol 1992; 24:365-373.
40. Dipla K, Mattiello JA, Margulies KB, Jeevanandam V, Houser SR. The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes. Circ Res 1999; 84:435-444.
41. Weisser-Thomas J, Piacentino V 3rd, Gaughan JP, Margulies K, Houser SR. Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovasc Res 2003; 57:974-985.
42. Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J, et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 2001; 103:670-677.
43. Gonzalez A, Ravassa S, Loperena I, Lopez B, Beaumont J, Querejeta R, et al. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens 2007; 25:2148-2157.
44. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997; 272:24684-24690.
45. Schieffer B, Luchtefeld M, Braun S, Hil?ker A, Hil?ker-Kleiner D, Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 2000; 87:1195-1201.
46. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004; 22:1141-1149.
47. Long C. Autocrine and paracrine regulation of myocardial cell growth in vitro: the TGF-beta paradigm. Trends Cardiovasc Med 1996; 6:217-226.
48. GrayMO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from ?broblasts. Cardiovasc Res 1998; 40:352-363.